Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer

Overview of attention for article published in Cancer Immunology, Immunotherapy, October 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 13,116 followers.

RT @WinshipAtEmory: A7: @DrMartinSanda et al. believe an "off the shelf" #prostatecancer immunotherapy can be developed: http://t.co/B8yKxq…

Reply Repost Favourite

A7: @DrMartinSanda et al. believe an "off the shelf" #prostatecancer immunotherapy can be developed: http://t.co/B8yKxqMUXT #PCSMFuture

Reply Repost Favourite

Development of a Peptide-Based Vaccine Targeting TMPRSS2:ERG Fusion-Positive #ProstateCancer http://t.co/gNTyLq5Nzj

Reply Repost Favourite